Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Fibroblast growth factor 2 up regulates telomerase activity in neural precursor cells

Abstract

During brain development, neuronal and glial cells are generated from neural precursors on a precise schedule involving steps of proliferation, fate commitment and differentiation. We report that telomerase activity is highly expressed during embryonic murine cortical neurogenesis and early steps of gliogenesis and progressively decreases thereafter during cortex maturation to be undetectable in the normal adult brain. We evidenced neural precursor cells (NPC) as the principal telomerase-expressing cells in primary cultures from E15 mouse embryo cortices. Their differentiation either in neurons or in glial cells lead to a down regulation of telomerase activity that was directly correlated to the decrease of telomerase core protein (mTERT) mRNA synthesis. Furthermore, we show that FGF2 (fibroblast growth factor 2), one of the main regulators of CNS development, induces a dose-dependant increase of both the proliferation of NPC and telomerase activity in primary cortical cultures without affecting the mTERT mRNA synthesis compared to that of glyceraldehyde-3-phosphate dehydrogenase (mGAPDH). Finally, we evidenced that AZT (3′-azido-2′,3′-dideoxythymidine), known to inhibit telomerase activity, blocks in a dose dependant manner the FGF2-induced proliferation of NPC. Altogether, our results are in favor of an important role of telomerase activity during brain organogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

Abbreviations

NPC:

neural precursor cells

FGF2:

fibroblast growth factor 2

NGF:

nerve growth factor

TERT:

telomerase reverse transcriptase protein

TER:

telomerase RNA

AZT:

3′-azido-2′,3′-dideoxythymidine

References

  • Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW and Harley CB . 1992 Proc Natl Acad Sci USA 89: 10114–10118

  • Altman J and Das GD . 1965 J Comp Neurol 124: 319–335

  • Blackburn EH . 1991 Nature 350: 569–573

  • Blasco MA, Funk W, Villeponteau B and Greider CW . 1995 Science 269: 1267–1270

  • Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA and Greider CW . 1997 Cell 91: 25–34

  • Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S and Wright WE . 1998 Science 279: 349–352

  • Cameron HA, Hazel TG and McKay RD . 1998 J Neurobiol 36: 287–306

  • Cattaneo E and McKay R . 1990 Nature 347: 762–765

  • Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P and de Lange T . 1995 Science 270: 1663–1667

  • Datta K, Bellacosa A, Chan TO and Tsichlis PN . 1996 J Biol Chem 271: 30835–30839

  • Dono R, Texido G, Dussel R, Ehmke H and Zeller R . 1998 EMBO J 17: 4213–4225

  • Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W and Moore MA . 1997 Blood 90: 182–193

  • Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West ND, Harley CB, Andrews WH, Grieder CW and Villeponteau B . 1995 Science 269: 1236–1241

  • Fu W, Begley JG, Killen MW and Mattson MP . 1999 J Biol Chem 274: 7264–7271

  • Gage FH, Coatesn PW, Palmer TD, Kuhn HG, Fisher LJ, Suhonen JO, Peterson DA, Suhr ST and Ray J . 1995 Proc Natl Acad Sci USA 92: 11879–11883

  • Ghosh A and Greenberg ME . 1995 Neuron 15: 89–103

  • Giordano S, Sherman L, Lyman W and Morrison R . 1992 Dev Biol 152: 293–303

  • Gomez DE, Tejera AM and Olivero OA . 1998 Biochem Biophys Res Commun 246: 107–110

  • Gray GE, Glover JC, Majors J and Sanes JR . 1988 Proc Natl Acad Sci USA 85: 7356–7360

  • Greenberg RA, Allsopp RC, Chin L, Morin GB and DePinho RA . 1998 Oncogene 16: 1723–1730

  • Greider CW . 1991 Mol Cell Biol 11: 4572–4580

  • Greider CW and Blackburn EH . 1985 Cell 43: 405–413

  • Harley CB . 1991 Mutat Res 256: 271–282

  • Harley CB, Futcher AB and Greider CW . 1990 Nature 345: 458–460

  • Herrera E, Samper E and Blasco MA . 1999a EMBO J 18: 1172–1181

  • Herrera E, Samper E, Martin-Caballero J, Flores JM, Lee HW and Blasco MA . 1999b EMBO J 18: 2950–2960

  • Hiratochi M, Fujiwara A, Kitani H, Iguchi T, Sakakura T and Tomooka Y . 1998 Dev Growth Differ 40: 59–65

  • Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA and Shay JW . 1995 Nat Med 1: 249–255

  • Holt SE, Wright WE and Shay JW . 1996 Mol Cell Biol 16: 2932–2939

  • Ito H, Kyo S, Kanaya T, Takakura M, Inoue M and Namiki M . 1998 Clin Cancer Res 4: 1603–1608

  • Janet T, Ludecke G, Otten U and Unsicker K . 1995 J Neurosci Res 40: 707–715

  • Joy A, Moffett J, Neary K, Mordechai E, Stachowiak EK, Coons S, Rankin-Shapiro J, Florkiewicz RZ and Stachowiak MK . 1997 Oncogene 14: 171–183

  • Kang SS, Kwon T, Kwon DY and Do SI . 1999 J Biol Chem 274: 13085–13090

  • Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW . 1994 Science 266: 2011–2015

  • Kruk PA, Balajee AS, Rao KS and Bohr VA . 1996 Biochem Biophys Res Commun 224: 487–492

  • Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW and DePinho RA . 1998 Nature 392: 569–574

  • Lendahl U, Zimmerman LB and McKay RD . 1990 Cell 60: 585–595

  • Makarov VL, Hirose Y and Langmore JP . 1997 Cell 88: 657–566

  • Martin-Rivera L, Herrera E, Albar JP and Blasco MA . 1998 Proc Natl Acad Sci USA 95: 10471–10476

  • Melana SM, Holland JF and Pogo BG . 1998 Clin Cancer Res 4: 693–696

  • Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA and Weinberg RA . 1997 Cell 90: 785–795

  • Miho Y, Kouroku Y, Fujita E, Mukasa T, Urase K, Kasahara T, Isoai A, Momoi MY and Momoi T . 1999 Cell Death Differ 6: 463–470

  • Miyagi N, Kato S, Terasaki M, Shigemori M and Morimatsu M . 1998 Int J Oncol 12: 1085–1090

  • Multani AS, Furlong C and Pathak S . 1998 Int J Oncol 13: 923–925

  • Murphy M, Reid K, Ford M, Furness JB and Bartlett PF . 1994 Development 120: 3519–3528

  • Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB and Cech TR . 1997 Science 277: 955–959

  • Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Ide T and Ishikawa F . 1998 Nat Genet 18: 65–68

  • Olivero OA and Poirier MC . 1993 Mol Carcinog 8: 81–88

  • Peyrin JM, Lasmezas CI, Haik S, Tagliavini F, Salmona M, Williams A, Richie D, Deslys JP and Dormont D . 1999 Neuroreport 10: 723–729

  • Prowse KR and Greider CW . 1995 Proc Natl Acad Sci USA 92: 4818–4822

  • Qian X, Davis AA, Goderie SK and Temple S . 1997 Neuron 18: 81–93

  • Ray J, Baird A and Gage FH . 1997 Proc Natl Acad Sci USA 94: 7047–7052

  • Reichman TW, Albanell J, Wang X, Moore MA and Studzinski GP . 1997 J Cell Biochem 67: 13–23

  • Reynolds BA, Tetzlaff W and Weiss S . 1992 J Neurosci 12: 4565–4574

  • Reynolds BA and Weiss S . 1996 Dev Biol 175: 1–13

  • Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC, Stein CA, Nichols G, Khaled Z, Telang NT and Narayanan R . 1995 Proc Natl Acad Sci USA 92: 12343–12346

  • Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP and Mak TW . 1998 Cell 95: 29–39

  • Strahl C and Blackburn EH . 1996 Mol Cell Biol 16: 53–65

  • Takakura M, Kyo S, Kanaya T, Tanaka M and Inoue M . 1998 Cancer Res 58: 1558–1561

  • Tian XX, Pang JC, To SS and Ng HK . 1999 J Neuropathol Exp Neurol 58: 472–479

  • Turner DL and Cepko CL . 1987 Nature 328: 131–136

  • Vaccarino FM, Schwartz ML, Raballo R, Nilsen J, Rhee J, Zhou M, Doetschman T, Coffin JD, Wyland JJ and Hung YT . 1999 Nat Neurosci 2: 246–253

  • Vaziri H and Benchimol S . 1998 Curr Biol 8: 279–282

  • van Weering DH, de Rooij J, Marte B, Downward J, Bos JL and Burgering BM . 1998 Mol Cell Biol 18: 1802–1811

  • Weng NP, Levine BL, June CH and Hodes RJ . 1996 J Exp Med 183: 2471–2479

  • Weng NP, Palmer LD, Levine BL, Lane HC, June CH and Hodes RJ . 1997 Immunol Rev 160: 43–54

  • Xu D, Gruber A, Bjorkholm M, Peterson C and Pisa P . 1999 Br J Cancer 80: 1156–1161

  • Yamaguchi Y, Nozawa K, Savoysky E, Hayakawa N, Nimura Y and Yoshida S . 1998 Exp Cell Res 242: 120–127

  • Zhu J, Wang H, Bishop JM and Blackburn EH . 1999 Proc Natl Acad Sci USA 96: 3723–3728

  • Zhu X, Kumar R, Mandal M, Sharma HW, Dhingra U, Sokoloski JA, Hsiao R and Narayanan R . 1996 Proc Natl Acad Sci USA 93: 6091–6095

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haïk, S., Gauthier, L., Granotier, C. et al. Fibroblast growth factor 2 up regulates telomerase activity in neural precursor cells. Oncogene 19, 2957–2966 (2000). https://doi.org/10.1038/sj.onc.1203596

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.onc.1203596

Keywords

This article is cited by

Search

Quick links